{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:59:33Z","timestamp":1790031573726,"version":"4.0.1"},"reference-count":23,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5761\/atcs.oa.14-00218","type":"journal-article","created":{"date-parts":[[2015,1,25]],"date-time":"2015-01-25T22:32:19Z","timestamp":1422225139000},"page":"217-222","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer"],"prefix":"10.5761","volume":"21","author":[{"given":"Keishi","family":"Kawasaki","sequence":"first","affiliation":[{"name":"Department of Surgery, Asahi General Hospital, Asahi, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Chiba University Hospital, Chiba, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Asahi General Hospital, Asahi, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhisa","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asahi General Hospital, Asahi, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Asahi General Hospital, Asahi, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Surgery, Asahi General Hospital, Asahi, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Detterbeck F. What to do with \u201cSurprise\u201d N2?: intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol 2008; 3: 289-302.","DOI":"10.1097\/JTO.0b013e3181630ebd"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: e314S-40S.","DOI":"10.1378\/chest.12-2360"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pisters KM, Evans WK, Azzoli CG, et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007; 25: 5506-18.","DOI":"10.1200\/JCO.2007.14.1226"},{"key":"4","unstructured":"4) Sobin LH, Gospodrowicz MK, Wittekind CH, editors. International Union against Cancer: TNM Classification of Malignant Tumours (7th edition). New York: Wiley-Blackwell, 2010."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76: 832-9.","DOI":"10.1016\/S0022-5223(19)39559-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4: 568-77.","DOI":"10.1097\/JTO.0b013e3181a0d82e"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) van Meerbeeck JP, Kramer GW, Van Schil PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007; 99: 442-50.","DOI":"10.1093\/jnci\/djk093"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Albain KS, Swann RS, Rusch VW, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009; 374: 379-86.","DOI":"10.1016\/S0140-6736(09)60737-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ichinose Y, Kato H, Koike T, et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 2001; 122: 803-8.","DOI":"10.1067\/mtc.2001.116473"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000; 18: 2981-9.","DOI":"10.1200\/JCO.2000.18.16.2981"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Suzuki K, Nagai K, Yoshida J, et al. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg 1999; 118: 145-53.","DOI":"10.1016\/S0022-5223(99)70153-4"},{"key":"12","unstructured":"12) Saito M, Kato H. Prognostic factors in patients with pathological and N2 non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2008; 14: 1-2."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Miller DL, McManus KG, Allen MS, et al. Results of surgical resection in patients with N2 non-small cell lung cancer. Ann Thorac Surg 1994; 57: 1095-1100, discussion 1100-1.","DOI":"10.1016\/0003-4975(94)91335-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Inoue M, Sawabata N, Takeda S, et al. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 2004; 127: 1100-6.","DOI":"10.1016\/j.jtcvs.2003.09.012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Riquet M, Bagan P, Le Pimpec Barthes F, et al. Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases. Ann Thorac Surg 2007; 84: 1818-24.","DOI":"10.1016\/j.athoracsur.2007.07.015"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yoshino I, Yoshida S, Miyaoka E, et al. Surgical outcome of stage IIIA- cN2\/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004. J Thorac Oncol 2012; 7: 850-5.","DOI":"10.1097\/JTO.0b013e31824c945b"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-60.","DOI":"10.1056\/NEJMoa031644"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008; 26: 3552-9.","DOI":"10.1200\/JCO.2007.13.9030"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shukuya T, Takahashi T, Tamiya A, et al. Actual status of adjuvant chemotherapy for non-small-cell lung cancer at one Japanese cancer center: the need for increased cooperation between medical oncologists and surgeons. Med Oncol 2010; 27: 932-7.","DOI":"10.1007\/s12032-009-9309-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Rusch VW, Crowley J, Giroux DJ, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2: 603-12.","DOI":"10.1097\/JTO.0b013e31807ec803"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sun Y, Gao W, Zheng H, et al. Mediastinal lymph-nodes metastasis beyond the lobe-specific: an independent risk factor toward worse prognoses. Ann Thorac Cardiovasc Surg 2014; 20: 284-91.","DOI":"10.5761\/atcs.oa.13-00028"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sakuraba M, Takahashi N, Oh S, et al. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2011; 17: 124-9.","DOI":"10.5761\/atcs.oa.09.01475"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 2000; 70: 358-65, discussion 365-6.","DOI":"10.1016\/S0003-4975(00)01673-8"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/21\/3\/21_oa.14-00218\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T16:09:22Z","timestamp":1651075762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/21\/3\/21_oa.14-00218\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.oa.14-00218","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}